ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.571,26
1,08%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Ambrx Biopharma Inc (AMAM)

  7. Ambrx Biopharma Inc (AMAM) News

AMAM

Ambrx Biopharma (AMAM)

Ambrx Biopharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:AMAM
DatumZeitQuelleÜberschriftSymbolFirma
12/10/202322h20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:AMAMAmbrx Biopharma Inc
12/10/202322h15Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:AMAMAmbrx Biopharma Inc
12/10/202322h10Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:AMAMAmbrx Biopharma Inc
12/10/202322h05Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:AMAMAmbrx Biopharma Inc
12/10/202312h04Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMAMAmbrx Biopharma Inc
10/10/202322h49Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMAMAmbrx Biopharma Inc
10/10/202317h35Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:AMAMAmbrx Biopharma Inc
06/10/202322h07Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMAMAmbrx Biopharma Inc
25/09/202323h24Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:AMAMAmbrx Biopharma Inc
07/07/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMAMAmbrx Biopharma Inc
28/06/202322h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
28/06/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NYSE:AMAMAmbrx Biopharma Inc
09/06/202322h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
09/06/202322h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
09/06/202322h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
09/06/202322h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
08/06/202322h06Edgar (US Regulatory)Current Report Filing (8-k)NYSE:AMAMAmbrx Biopharma Inc
25/05/202322h08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:AMAMAmbrx Biopharma Inc
18/05/202322h28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:AMAMAmbrx Biopharma Inc
18/05/202322h24Edgar (US Regulatory)Current Report Filing (8-k)NYSE:AMAMAmbrx Biopharma Inc
16/05/202322h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:AMAMAmbrx Biopharma Inc
11/05/202322h08Edgar (US Regulatory)Quarterly Report (10-q)NYSE:AMAMAmbrx Biopharma Inc
05/05/202322h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
05/05/202322h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:AMAMAmbrx Biopharma Inc
04/05/202322h12Edgar (US Regulatory)Current Report Filing (8-k)NYSE:AMAMAmbrx Biopharma Inc
29/04/202300h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
29/04/202300h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
28/04/202322h22Edgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:AMAMAmbrx Biopharma Inc
28/04/202322h09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:AMAMAmbrx Biopharma Inc
27/04/202322h11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:AMAMAmbrx Biopharma Inc
 Showing the most relevant articles for your search:NYSE:AMAM

Kürzlich von Ihnen besucht

NYSE
JPM
JP Morgan Chase
TG
432
Arbor Metals
PM
XAUUSD
Gold vs US Dollar
DBI
SDXP
SDAX
NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
NVDA
NVIDIA
USOTC
RHHBY
Roche (QX)
TG
NOV
Novo Nordisk
USOTC
BASFY
BASF (QX)
COIN
SOLUSD
Solana
DBI
DAX
DAX
USOTC
BNPQY
BNP Paribas (QX)
AMEX
SPY
SPDR S&P 500
TG
DTE
Deutsche Telekom
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten